Advertisement
Home Tags Clots

Tag: Clots

Rate of Venous Thromboembolism Increased With Cancer Surgery

Cause-specific hazard ratio for pulmonary embolism peaked after discharge, then plateaued 60 to 90 days later

Bivalent COVID-19 Shot Effective for Preventing Thromboembolic Events

Findings seen for adults aged 65 years and older and for those aged 18 years and older with end-stage renal disease

Clot Risk High With Oral Contraceptives for Those at Genetic Risk

Risk highest in the first two years, regardless of genetic risk, and lower for continued use

Mechanical Thrombectomy Safe, Effective for High-Risk Pulmonary Embolism

No deaths seen at 30-day follow-up in real-world cohort

Estrogen-Linked Thrombotic Biomarkers Drop After Cessation of Combo Pill

Decreases seen at week 12, with most of the decrease achieved at two and four weeks after cessation of combined hormonal contraceptives

Link Explored for NSAID Use, Hormonal Contraception, VTE Risk

NSAID use positively linked to VTE, with extra VTE events in those with concomitant high-, medium-risk contraception use

Pulmonary Embolism-Related Mortality Remained Unchanged From 2006 to 2019

Age-adjusted mortality rate increased for men versus women and Black versus White patients

Prolonged Direct Oral Anticoagulants Beneficial for Preventing Recurrent VTE

Findings seen among adults prescribed warfarin, DOACs beyond six months after acute venous thromboembolism

New Eligibility Criteria May Increase Endovascular Thrombectomy Rates

Findings based on several criteria in patients with ischemic stroke due to anterior circulation large vessel occlusions

Concerning CT Findings Increase Health Care Utilization With Low-Risk Pulmonary Embolism

However, no short-term adverse clinical outcomes seen for these patients versus low-risk patients without concerning findings